South Dakota Medication Aide Practice Test

When administering neomycin (Neo-Fradin), it is crucial to report and record dizziness, tinnitus, signs of hearing loss, and bloody or smoky-colored urine because these symptoms may indicate serious adverse effects associated with the medication. Neomycin, being an aminoglycoside antibiotic, has known nephrotoxic and ototoxic potential. This means it can cause damage to the kidneys (evidenced by changes in urine color) and can adversely affect hearing, which is often portrayed through symptoms such as dizziness and tinnitus.

Monitoring for these specific signs is essential for patient safety, as they may point to toxic reactions that necessitate medical intervention. Reporting these symptoms helps ensure that healthcare providers can take appropriate action to mitigate any potential harm from the medication. Recognizing and documenting these adverse effects is a vital part of the medication administration process to maintain the patient's well-being and to comply with medical standards.